Impact of coronary microvascular function on long-term cardiac mortality in patients with acute ST-segment-elevation

Tim P van de Hoef1, Matthijs Bax, Martijn Meuwissen

  • 1Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Insights

Microvascular dysfunction in coronary arteries after ST-elevation myocardial infarction indicates higher long-term cardiac mortality risk. Assessing coronary flow velocity reserve (CFVR) post-intervention is crucial for predicting patient outcomes.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Interventional Cardiology

Background:

  • Microvascular function is a key risk marker in coronary artery disease.
  • Intracoronary Doppler flow velocity measurements accurately assess microvascular function.
  • Limited data exist on the long-term prognostic value of microvascular function in ST-segment-elevation myocardial infarction (STEMI).

Purpose of the Study:

  • To determine the prognostic value of microvascular function for cardiac mortality in STEMI patients.
  • To assess microvascular function using Doppler flow velocity measurements post-primary percutaneous coronary intervention (PCI).
  • To evaluate the impact of microvascular function in both infarct-related and reference coronary arteries on long-term clinical outcomes.

Main Methods:

  • 100 consecutive STEMI patients undergoing primary PCI were included.
  • Intracoronary Doppler flow velocity was measured post-PCI in infarct-related and reference arteries.
  • Coronary flow velocity reserve (CFVR), diastolic deceleration time, and systolic retrograde flow were assessed.
  • The primary endpoint was cardiac mortality at 10-year follow-up.

Main Results:

  • 14% of patients experienced cardiac mortality at 10-year follow-up.
  • Cardiac mortality was 5% with normal reference vessel CFVR (≥2.1) versus 31% with abnormal CFVR (<2.1).
  • Abnormal reference vessel CFVR (<2.1) independently predicted a 4.09-fold increase in long-term cardiac mortality hazard (HR, 4.09; P=0.03).

Conclusions:

  • Microvascular dysfunction, indicated by abnormal reference vessel CFVR after primary PCI in STEMI, significantly increases long-term cardiac mortality risk.
  • Reference vessel CFVR is a valuable prognostic marker for long-term outcomes in STEMI patients.
  • Doppler-derived microvascular assessment provides critical prognostic information in acute myocardial infarction management.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...